The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2015
Filed:
Oct. 30, 2013
Applicant:
Intra-cellular Therapies Inc., New York, NY (US);
Inventors:
Sharon Mates, New York, NY (US);
Allen Fienberg, New York, NY (US);
Lawrence P. Wennogle, New York, NY (US);
Assignee:
INTRA-CELLULAR THERAPRIES, INC., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/535 (2006.01); A01N 43/58 (2006.01); A01N 43/60 (2006.01); A61K 31/50 (2006.01); A61K 31/495 (2006.01); A61K 9/48 (2006.01); A61K 31/5383 (2006.01); A61K 31/44 (2006.01); A61K 31/4985 (2006.01); A61K 45/06 (2006.01); C07D 471/14 (2006.01); C07D 498/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5383 (2013.01); A61K 31/44 (2013.01); A61K 31/4985 (2013.01); A61K 45/06 (2013.01); C07D 471/14 (2013.01); C07D 498/14 (2013.01);
Abstract
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving the 5-HT2A, SERT and/or dopamine D2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or Parkinson's disease or any combinations.